Monoclonal antibodies for migraine prevention: hope, hype, and health economy challenge
Br J Gen Pract
.
2020 Jul 30;70(697):e523-e524.
doi: 10.3399/bjgp20X711833.
Print 2020 Aug.
Author
David Kernick
1
Affiliation
1
Exeter Headache Clinic, St Thomas's Health Centre, Exeter, UK.
PMID:
32732219
PMCID:
PMC7384840
DOI:
10.3399/bjgp20X711833
No abstract available
Publication types
Editorial
MeSH terms
Antibodies, Monoclonal*
Humans
Migraine Disorders* / drug therapy
Migraine Disorders* / prevention & control
Substances
Antibodies, Monoclonal